Carvana Wedbush Upgrade Lifts Shares

Carvana Wedbush upgrade raised its 12-month price target to $400 and flagged unit growth and margin expansion, prompting renewed trader interest.

November 24, 2025·2 min read
View all news articles
Flat vector icon of a car merged with growth bands to represent Carvana Wedbush upgrade and unit growth forecasts.

KEY TAKEAWAYS

  • Wedbush upgraded Carvana to Outperform and raised its 12-month price target to $400.
  • The note forecast Q4 revenue of $5.2 billion and FY 2025 revenue of $19.9 billion.
  • Wedbush cited accelerating unit growth and margin expansion as the rationale.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Wedbush Securities upgraded Carvana (CVNA) to Outperform from Neutral on Nov. 24, 2025, citing stronger management execution, accelerating unit growth, and margin expansion. The firm raised its 12-month price target to $400 from $380, prompting shares to rise more than 7% following the note.

Wedbush Upgrade and Valuation

Wedbush viewed Carvana’s recent roughly 13% share price pullback as excessive and a buying opportunity. The firm values Carvana at about 22 times its 2027 earnings estimate, near the low end of the stock’s two-year trading range. The upgrade reflects confidence in the company’s ability to sustain growth and improve profitability.

Growth and Margin Outlook

Wedbush projects Carvana’s revenue will reach $5.2 billion in the fourth quarter of 2025, up 46.4% year-over-year, and $19.9 billion for the full year, a 45.6% increase. These gains are driven mainly by a 41.4% rise in used-unit sales, supported by sustained unit expansion and improved per-unit economics.

The firm expects Carvana to surpass CarMax in quarterly used-unit volumes by the fourth quarter of 2026, forecasting about 187,000 units compared with CarMax’s 170,000. Wedbush projects Carvana will scale to 3 million annual retail unit sales by 2033, implying a compound annual growth rate of at least 23% through that year.

Adjusted EBITDA margins are forecast to reach 12% by 2027, moving toward management’s longer-term target of 13.5% within five to ten years. Wedbush noted limited concern about credit performance despite Carvana’s expansion into lower-prime and subprime financing.

The firm’s valuation and profit assumptions underpin the higher price target and suggest potential for a re-rating if Carvana meets its volume and margin forecasts.

The near-term test of Wedbush’s outlook will come with Carvana’s fourth-quarter 2025 results and whether unit volumes and revenue align with projections. Progress toward the projected volume lead in late 2026 and the longer-term sales and margin goals will influence future valuation assessments.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Rubrik Q3 Earnings Show Profit Turnaround

Rubrik Q3 Earnings Show Profit Turnaround

Rubrik Q3 earnings beat expectations with near fifty percent revenue growth and its first positive non-GAAP operating income, shifting trader positioning.

Samsara Q3 Earnings Show Profitability, Slowing Guidance

Samsara Q3 Earnings Show Profitability, Slowing Guidance

Samsara Q3 earnings showed the company's first GAAP profit on Dec. 4, 2025, with 29% ARR growth but guidance slowed and muted near-term stock reaction.

HPE Earnings Hurt by Server Revenue Slide

HPE Earnings Hurt by Server Revenue Slide

HPE earnings reported growth but warned that delayed AI server deals and server revenue decline pressured guidance and knocked shares lower after-hours.

Ulta Beauty Q3 Earnings Beat, Company Raises Outlook

Ulta Beauty Q3 Earnings Beat, Company Raises Outlook

Ulta Beauty Q3 earnings topped forecasts and management raised full-year sales to $12.3 billion, sending shares higher and signaling resilience in beauty.

Hims & Hers Canada Expansion Targets Weight Loss

Hims & Hers Canada Expansion Targets Weight Loss

Hims & Hers Canada expansion follows an all-cash Livewell acquisition and sets up a GLP weight-loss program timed to expected generic semaglutide.

New York Times Sues Pentagon Over Press Rules

New York Times Sues Pentagon Over Press Rules

New York Times sues Pentagon over revised press-access policy on Dec. 4, 2025, seeking to block enforcement and restore credentials, raising NYT legal risk